Ruiling Xu
Impact in
- Rehabilitation top 5%
- Wound Healing and Treatments
Papers in
-
- Sarcoma Diagnosis and Treatment 10
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Yujiang Fan (11 shared papers)Xingdong Zhang (10 shared papers)Jie Liang (10 shared papers)Jo Anna Reems (2 shared papers)Han De-wu (4 shared papers)Yuanchang Zhao (4 shared papers)Yong Sun (10 shared papers)Huiwen Wu (2 shared papers)
- Journals
- Advanced Science (3 papers)Transfusion (2 papers)Journal of Controlled Release (2 papers)ACS Nano (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ruiling Xu
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Drug Discovery 5
- Rehabilitation 75
- Molecular Medicine 56
- Biomaterials 105
- Pharmaceutical Science 27
Countries citing papers authored by Ruiling Xu
This map shows the geographic impact of Ruiling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiling Xu more than expected).
Fields of papers citing papers by Ruiling Xu
This network shows the impact of papers produced by Ruiling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiling Xu. The network helps show where Ruiling Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruiling Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 98 | |
| 2 | 2014 | 90 | |
| 3 | 2020 | 78 | |
| 4 | 1998 | 69 | |
| 5 | 2022 | 68 | |
| 6 | 2023 | 60 | |
| 7 | 2022 | 58 | |
| 8 | 2020 | 46 | |
| 9 | 2016 | 34 | |
| 10 | 2001 | 30 | |
| 11 | 2022 | 26 | |
| 12 | 2021 | 24 | |
| 13 | 2017 | 23 | |
| 14 | 2022 | 23 | |
| 15 | 2022 | 22 | |
| 16 | 2010 | 21 | |
| 17 | 2022 | 21 | |
| 18 | 2023 | 20 | |
| 19 | 2013 | 19 | |
| 20 | 2020 | 19 |
About Ruiling Xu
Ruiling Xu is a scholar working on Pulmonary and Respiratory Medicine, Biomaterials, Oncology, Hepatology and Molecular Biology, having authored 61 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (10 papers), Liver physiology and pathology (4 papers), Gut microbiota and health (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Wound Healing and Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Drug Discovery (5 citations), Rehabilitation (75 citations), Molecular Medicine (56 citations), Biomaterials (105 citations) and Pharmaceutical Science (27 citations). Ruiling Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yujiang Fan, Xingdong Zhang, Jie Liang, Jo Anna Reems, Han De-wu, Yuanchang Zhao, Yong Sun, Huiwen Wu, Zhihong Li and Lei Tong. Their work appears in journals such as Advanced Science, Transfusion, Journal of Controlled Release, ACS Nano and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.